SANDOZ INC FDA Approval ANDA 090862

ANDA 090862

SANDOZ INC

FDA Drug Application

Application #090862

Documents

Review2012-09-12

Application Sponsors

ANDA 090862SANDOZ INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS200MG/VIAL0VORICONAZOLEVORICONAZOLE

FDA Submissions

ORIG1AP2012-05-30
LABELING; LabelingSUPPL2AP2015-10-23STANDARD
LABELING; LabelingSUPPL8AP2021-06-22STANDARD
LABELING; LabelingSUPPL9AP2021-06-22STANDARD
LABELING; LabelingSUPPL10AP2021-06-22STANDARD
LABELING; LabelingSUPPL11AP2021-06-22STANDARD
LABELING; LabelingSUPPL12AP2021-06-22STANDARD
LABELING; LabelingSUPPL13AP2021-06-22STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15
SUPPL8Null7
SUPPL9Null15
SUPPL10Null15
SUPPL11Null7
SUPPL12Null7
SUPPL13Null7

TE Codes

001PrescriptionAP

CDER Filings

SANDOZ INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90862
            [companyName] => SANDOZ INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"VORICONAZOLE","activeIngredients":"VORICONAZOLE","strength":"200MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"VORICONAZOLE","submission":"VORICONAZOLE","actionType":"200MG\/VIAL","submissionClassification":"INJECTABLE;INTRAVENOUS","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.